Apatinib in the treatment of advanced lung adenocarcinoma with KRAS mutation

Apatinib in the treatment of advanced lung adenocarcinoma with KRAS mutation

Da-xiong Zeng,* Chang-guo Wang,* Jian-an Huang, Jun-hong Jiang Department of Respiratory and Critical Care, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, People’s Republic of China *These authors contributed equally to this work Abstract: Activating KRAS mutation...

Full description

Bibliographic Details
Main Authors: Zeng D, Wang C, Huang J, Jiang J
Format: Article
Language:English
Published: Dove Medical Press 2017-08-01
Series:OncoTargets and Therapy
Subjects:
lung cancer
apatinib
VEGFR-2
KRAS mutation
Online Access:https://www.dovepress.com/apatinib-in-the-treatment-of-advanced-lung-adenocarcinoma-with-kras-mu-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/apatinib-in-the-treatment-of-advanced-lung-adenocarcinoma-with-kras-mu-peer-reviewed-article-OTT

Similar Items